Connect with us

Media OutReach

CR Construction Announces Annual Results

Published

on

Recorded Double-Digit Growth in Revenue and Gross Profit, Proposed a Final Dividend of HK1.8 Cents per Share

Highlights:

  • Revenue increased by 11.4% to approximately HK$6,066.0 million.
  • Revenue generated from building construction works increased by 15.1% to HK$5,414.5 million.
  • Gross profit increased by 15.4% to HK$353.2 million.
  • Basic earnings per share was HK10.74 cents. The Board recommended the payment of final dividend of HK1.8 cents per share.


Financial Highlights:

For the year ended 31 Dec 2024
HK$’000 2024 2023 Change
Revenue

  • Building Construction Works
  • Repair, Maintenance, Alteration and Addition (“RMAA”)
  • Environmental Operations
6,066,037

5,414,578
511,985
139,474

5,445,560

4,703,000
528,681
213,879

+11.4%

+15.1%
-3.2%
-34.8%

Gross profit
Gross profit margin
353,232
5.8%
305,991
5.6%
+15.4%
+0.2 ppts.
Net profit (attributable to Owners of the Company) 53,715 71,887 -25.3%
Earnings per share (HK cents) 10.74 14.38 -25.3%

HONG KONG SAR – Media OutReach Newswire – 21 March 2025 – CR Construction Group Holdings Limited (“CR Construction” or the “Company”, together with its subsidiaries, the “Group”; stock code: 1582.HK), a building contractor in Hong Kong, announced its annual results for the year ended 31 December 2024 (the “Financial Year under Review”).

During the Financial Year under Review, the revenue recorded by the Group amounted to approximately HK$6,066.0 million representing an increase of approximately 11.4% as compared to approximately HK$5,445.6 million for the year ended 31 December 2023 (the “Corresponding Period Last Year”). Net profit of the Group (attributable to Owners of the Company) during the Financial Year under Review was approximately HK$53.7 million.

During the Financial Year under Review, gross profit of the Group was approximately HK$353.2 million, representing an increase of approximately 15.4% as compared to approximately HK$306.0 million for the Corresponding Period Last Year. The Group’s gross profit margin was approximately 5.8% and 5.6% for the year ended 31 December 2024 and 2023, respectively.

During the Financial Year under Review, earnings per share of the Group was approximately HK10.74 cents (for the year ended 31 December 2023: HK14.38 cents). The Board recommended the payment of final dividend of HK1.8 cents per share.

BUSINESS REVIEW

Construction Operations
Building Construction Works

For the year ended 31 December 2024, the revenue generated from the building construction works was HK$5,414.5 million, representing an increase of approximately 15.1% as compared to approximately HK$4,703.0 million for the year ended 31 December 2023.

During the Financial Year under Review, the gross profit of building construction works was approximately HK$238.1 million, representing an increase of approximately 16.5% as compared to approximately HK$204.4 million for the Corresponding Period Last Year. The gross profit margin was approximately 4.4% for the year ended 31 December 2024.

Repair, Maintenance, Alteration and Addition (“RMAA”)

The revenue generated from the RMAA works decreased by approximately 3.2% from approximately HK$528.7 million for the year ended 31 December 2023 to approximately HK$512.0 million for the year ended 31 December 2024. The decrease was mainly attributable to existing projects were closed to completion during the Financial Year under Review.

During the Financial Year under Review, the gross profit of RMAA works was approximately HK$70.9 million, representing an increase of approximately 14.9% as compared to approximately HK$61.7 million for the Corresponding Period Last Year. The gross profit margin increased by approximately 2.1 ppts to approximately 13.8%.

Environmental Operations

The revenue generated from the environmental operations was decreased from approximately HK$213.9 million for the Corresponding Period Last Year to approximately HK$139.5 million for the Financial Year under Review. The decrease was mainly attributable to decrease in revenue from new and existing projects from construction and rehabilitation services, which was partially offset by increase from sewage and reclaimed water treatment services, during the Financial Year under Review.

During the Financial Year under Review. The gross profit of environmental operations was approximately HK$44.2 million, representing an increase of approximately 10.8% as compared to approximately HK$39.9 million for the Corresponding Period Last Year. The gross profit margin increased by approximately 13 ppts to approximately 31.7%.

CONTRACT COSTS

The Group’s contract costs primarily consisted of subcontracting costs, material costs, direct staff costs, site overheads and provision for rectification works and claims. For the year ended 31 December 2024, the contract costs recorded by the Group were approximately HK$5,712.8 million, representing an increase of approximately 11.2% compared to approximately HK$5,139.6 million for the year ended 31 December 2023.

PROSPECTS

Subsequent to 31 December 2024, the Group has been further awarded 4 new projects relating to 2 building construction works contracts with original contract sum of approximately HK$4.1 billion and 2 RMAA works contract and with original contract sum of approximately HK$22.4 million.

The Group has also placed significant emphasis on technological innovation to enhance its core competitiveness in the construction industry. The total expenditure for research and development was approximately by HK$20.1 million.

During the Financial Year under Review, the Group has improved our “Smart Site Safety System (4S)” and successfully obtained the ISO27001 certification. There are several key modules had been optimised, including adding the Hong Kong Observatory’s real-time data to the system platform, enhancing the data interface visualization, advancing RFID equipment and systems, which further enhanced the efficiency of the tower crane and mobile plant safety alert systems, better meeting the practical needs of site workers. In addition, the Group has successfully developed a Safety Tracking Watch for construction sites, which can real-time monitor the location and health status of site workers, providing comprehensive safety protection. At the same time, the company has also optimised the certificate module in the training system, adding OCR scanning and data tracking functions to improve asset management efficiency and user experiences.

The Group has also signed a memorandum of understanding (“MOU”) with the Hong Kong Centre for Construction Robotics, strengthening the collaboration in the area of innovation in the construction industry, such as smart construction technology research and development, robotics applications, talent cultivation, and commercialization. The joint efforts aim to promote intelligence and sustainability in the construction industry.

In addition, the ZCIEE has successfully developed an integrated rural domestic sewage treatment equipment, which has already passed the performance test by a third-party testing institution. The equipment has successfully achieved commercialized sales, marking an important step for the company in converting its proprietary technology into economic benefits.

The Group will enhance its technology research and development, and is committed to introducing various innovative technology tools in both construction and environmental projects to improve management efficiency, construction safety and environmental protection.

Since the sentiment of the property market is gradually stabilising, the outlook for 2025 should remain stable. Additionally, with ongoing projects in new development areas like the Northern Metropolis, they are expected to have a positive impact on our Group’s business. However, the Group will still face challenges such as talent shortages, increasing skilled labour and material costs in the construction industry.

To address these challenges, the Group will continue to enhance the utilisation of the Labour Importation Scheme for the Construction Sector and focus on identifying new and potential construction opportunities for profitable growth. In addition, leveraging our industry experience and expertise, our Group is keen to explore suitable business opportunities in the construction sector both locally and overseas.Hashtag: #CRConstruction #華營建築 #AnnualResults

The issuer is solely responsible for the content of this announcement.

CR Construction Group Holdings Limited

CR Construction Group Holdings Limited, which is carrying out construction business for over 55 years locally, is one of the leading building contractors in Hong Kong. The Group principally act as a main contractor in building construction works and RMAA works projects across public and private sectors in Hong Kong. As a main contractor, the Group is responsible for (i) overall management of the projects; (ii) formulating work programmes; (iii) engaging subcontractors and supervising their works; (iv) sourcing construction materials; (v) communication and coordination with the customers and their consultant teams; and (vi) safeguarding compliance with safety, environmental and other contractual requirements.

Advertisement

Media OutReach

St. George’s University Prepares Future South Korean Physicians for the Growing Global Cancer Care Challenge

Published

on

SEOUL, SOUTH KOREA – Media OutReach Newswire – 4 February 2026 – Rising global cancer incidence is straining healthcare systems, which already face workforce shortages. In East Asia, the number of trained physicians in cancer care, spanning diagnosis, treatment coordination, and long-term management—has not met the increasing demand. According to the Global Cancer Observatory, South Korea reported over 230,000 new cancer cases and more than 97,000 fatalities in 2022. A recent original academic research by Myongji College and The Catholic University of Korea warned that simply increasing medical school enrollments alone does not fix shortages in key specialties and underserved regions where medical demand is rising fastest.

Source: St. George’s University

Recognizing the importance of addressing workforce shortage in South Korea, St. George’s University (SGU) School of Medicine in Grenada, West Indies, highlights how its medical education approach supports the development of clinical competencies relevant to cancer care across healthcare settings.

These challenges reflect broader global trends, where cancer care increasingly depends on multidisciplinary teams rather than specialty expansion alone. SGU’s curriculum is designed to build a strong foundation in clinical diagnosis, patient communication and multidisciplinary care, which are essential skills for effective oncology and cancer-related care. Through anatomy labs, simulation-based learning, and integrated digital tools, students develop foundational clinical skills in structured, supervised environments designed to reflect real-world medical practice.

The curriculum also integrates traditional cadaveric dissection with modern 3D anatomical modeling. This blend helps students visualize the human body in a holistic way while reinforcing knowledge through their hands-on interaction. SGU’s simulation lab also enables medical students to have their first direct interaction with ill patients in a safe, simulated learning environment.

On top of core medical training, SGU offers early exposure to prevention, diagnosis and patient-centered care to prepare graduates to tackle complex health issues. SGU has developed long-standing relationships with more than 75 established hospitals and clinical centers in the US and UK. These clinical placements provide exposure to diverse patient populations and care environments, including settings where cancer diagnosis and management are part of routine clinical practice.

South Korean SGU alumni are contributing to healthcare systems through roles that intersect with cancer diagnosis, treatment coordination, and long-term patient care. For example, Dr. Julia Hweyryoung Cho, MD 2022 is practicing internal medicine, which plays a crucial role in cancer care. Internal medicine physicians are often involved in the initial diagnosis of cancer, managing complex medical conditions that may arise during treatment and providing long-term comprehensive care and survivorship planning for patients with a history of cancer.

In observance of World Cancer Day 2026, SGU encourages all medical professionals and organizations to collaboratively address global cancer care challenges. This includes recognizing and meeting the cancer healthcare needs of individuals and communities in South Korea.

For more information on the programs and tracks available through SGU School of Medicine, visit SGU’s website.Hashtag: #St.George’sUniversity

The issuer is solely responsible for the content of this announcement.

Continue Reading

Media OutReach

Finalists and Semifinalists for $1 Million Seeding The Future Global Food System Challenge Announced

Published

on

BONN, GERMANY – Newsaktuell – 3 February 2026 – The Seed Grant Finalists and Growth Grant and Seeding the Future Grand Prize Semifinalists of the 5th annual Seeding The Future Global Food System Challenge (GFSC) have been announced, marking a key milestone in the USD 1 million global Challenge supporting impactful and innovative solutions to transform food systems.

Created and funded by Seeding The Future Foundation and, for the first time, hosted by Welthungerhilfe (WHH), the Challenge attracted a record 1,600+ applications from innovator teams in 112 countries, underscoring growing global momentum for food systems transformation.

Following a multi-stage, rigorous international review process, 36 teams have advanced across three award levels. These include 16 Seed Grant Finalists (competing for 8 awards of USD 25,000), 12 Growth Grant Semifinalists (competing for 3 awards of USD 100,000), and 8 Seeding The Future Grand Prize Semifinalists (competing for 2 awards of USD 250,000).

“Hosting the GFSC reflects Welthungerhilfe’s commitment to accelerating bold, scalable innovations where they are needed most. This year’s diversity of solutions underscores the complexity of food system challenges and the creativity of innovators worldwide.” said Jan Kever, Head of Innovation at Welthungerhilfe

The submitted innovations span diverse themes and approaches, including climate-smart production, nutrient-dense foods, food loss reduction, and inclusive market models, reflecting the complexity and interconnected nature of today’s food systems challenges.

“The Seeding The Future Global Food System Challenge exists to catalyze impactful, bold, and scalable innovations that advance food systems transformation. We are excited to work alongside Welthungerhilfe as a trusted partner and host of the Challenge and are encouraged by the quality and diversity of innovations emerging from this first year of collaboration.” said Bernhard van Lengerich, Founder and CEO of Seeding The Future Foundation

While the number of awards is limited, all semifinalists and finalist applicants plus all applicants with any prior recognition of other innovation competitions can join the STF Global Food System Innovation Database and Network—currently in beta testing with the Food and Agriculture Organization of the United Nations—vastly expanding their visibility and reach across a global audience.

List of 2025 GFSC Seed Grant Finalists, Growth Grant and Seeding The Future Grand Prize Semifinalists

Find details here: welthungerhilfe.org/gfsc-finalists

Seeding The Future Grand Prize Semi-Finalists

Growth Grant Semi-Finalists

Seed Grant Finalists

Hashtag: #TheFutureGlobalFoodSystemChallenge

The issuer is solely responsible for the content of this announcement.

About Seeding The Future Foundation

STF is a private nonprofit dedicated to ensuring equitable access to safe, nutritious, affordable, and trusted food. It supports innovations that transform food systems and benefit both people and planet. More at .

About Welthungerhilfe
WHH is one of Germany’s largest private aid organizations, striving for a world without hunger since 1962. More at:

Continue Reading

Media OutReach

PolyU develops novel antibody targeting fat cell protein, offering new approach to treating metabolism-related liver cancer

Published

on

HONG KONG SAR – Media OutReach Newswire – 3 February 2026 – Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become increasingly common in recent years. A research team from The Hong Kong Polytechnic University (PolyU) has identified a protein secreted by fat cells that promotes cancer growth and has successfully developed a novel antibody that neutralises this protein, marking a significant breakthrough in impeding the progression of liver cancer. The research findings have been published in the Journal of Clinical Investigation.

Prof. Terence Lee, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology, and his research team have developed a novel antibody targeting the adipocyte-derived protein FABP4, offering a new approach to treating metabolism-related liver cancer.

Metabolic dysfunction-associated steatotic liver disease (MASLD), commonly known as fatty liver disease, currently affects around a quarter of the global population and is an important risk factor for liver cancer. In affected individuals, fat cells induce insulin resistance and chronic inflammation, leading to excessive fat accumulation in the liver. This ultimately impairs liver function and may progress to liver cancer. Treatment options for MASLD-induced liver cancer remain limited and the effectiveness of current immunotherapies is suboptimal.

A breakthrough study led by Prof. Terence LEE, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology, and his research team has revealed that an adipocyte-derived protein, known as fatty acid-binding protein 4 (FABP4) is a key driver that accelerates tumour growth. Through mass spectrometry, the team confirmed that patients with MASLD-induced liver cancer had markedly elevated FABP4 levels in their serum. Further investigations showed that FABP4 activates a series of pro-proliferative signalling pathways within cells, causing cancer cells to multiply and grow more rapidly.

Prof. Lee’s team has successfully developed a monoclonal antibody that neutralises FABP4. This antibody not only inhibits the growth and proliferation of FABP4-driven cancer stem cells, but also enhances the ability of immune cells to combat cancer.

Prof. Lee said, “This neutralising antibody against FABP4 demonstrates significant potential in inhibiting tumour growth and activating immune cells, providing a complementary approach to current immunotherapy strategies. Our findings highlight that targeting adipocyte-derived FABP4 holds promise for treating MASLD-induced liver cancer.”

Prof. Lee added that gaining deeper insights into how adipocyte-derived FABP4 affects liver cancer cells helps to explicate the disease mechanisms of liver cancer, particularly in obese individuals. Intervening in the relevant signalling pathways could provide effective methods to combat this aggressive malignancy.

Prof. Lee believes that, as this adipocyte-targeted immunotherapy continues to mature, it will bring more treatment options to MASLD patients. He remarked, “If its efficacy can be proven in clinical trials, it could offer new hope to many affected individuals.”

The research is supported by the Innovation and Technology Fund of the Innovation and Technology Commission of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China. PolyU has filed a non-provisional patent for the developed antibody and is continuing to optimise its binding affinity to facilitate future clinical applications.
Hashtag: #PolyU #FattyLiver #Cancer #LiverCancer #理大 #香港理工大学 #肝癌 #癌症 #脂肪肝

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending